Certain pharmaceuticals and medicines
In 2017, scientists discovered evidence suggesting that certain cannabis compounds may induce schizophrenia in susceptible individuals. Others have suggested that schizophrenia may increase an individual’s likelihood of using cannabis in the first place. It is not well understood what causes schizophrenia, but researchers believe that a combination of genetic, environmental, and brain chemical factors contribute to the disorder’s development. Schizophrenia may be caused by problems with glutamate and dopamine, which are neurotransmitters that occur naturally in the brain.
Studies of neuroimaging disclose differences in the central nervous system and brain structure of schizophrenic individuals. Although researchers are uncertain as to the significance of these variations, they demonstrate that schizophrenia is a neurological disorder. The precise cause of schizophrenia is still unknown. However, schizophrenia, like diabetes and cancer, is a true disease with a biological cause. Researchers have not examined a number of factors that increase a person’s risk of developing schizophrenia, including:
